IP and Life Sciences Transactional Lawyer Joins Latham & Watkins in New York

Addition of experienced transactional lawyer further strengthens Latham’s intellectual property practice and enhances life sciences, pharmaceutical and technology industry practices.

March 26, 2012

New York … Latham & Watkins LLP1 is pleased to announce that Eliot S. Choy has joined the firm’s New York office as counsel in the technology transaction group of the Corporate Department. Choy brings to the firm more than a decade of experience as a transactional attorney specializing in intellectual property, life sciences, pharmaceuticals and technology, with a particular focus on the acquisition, divestiture, development, and commercialization of pharmaceutical products. He also regularly advises pharmaceutical clients with respect to transactions surrounding Abbreviated New Drug Applications (ANDAs), including product acquisitions and negotiating and structuring settlements of ANDA litigations.

Advising clients across a number of industries, including: pharmaceuticals, biotechnology, software, and outsourcing, Choy has extensive experience in negotiating and drafting a broad range of agreements involving the transfer, use and sharing of intellectual property. “We are delighted to welcome Eliot to the firm,” said James Brandt, Office Managing Partner of Latham & Watkins in New York. “His deep intellectual property experience across a number of industry sectors will further enhance our litigation and corporate practices, particularly in the life sciences sector.”

James Gorton, Global Co-Chair of the Corporate Department, added: “Eliot’s skill set is a boost to our active IP practice. His experience in mergers and acquisitions coupled with his deep knowledge of the pharmaceuticals, life sciences and technology industries will be an asset to our global client base.”

“Latham’s well-established intellectual property and corporate platforms were a big draw for me and I look forward to growing my practice,” said Choy. “I am excited about the opportunity to help expand the firm’s IP capabilities in both litigation and corporate matters.”

Choy’s addition to Latham’s intellectual property practice follows partner Daniel Brown, who specializes in patent litigation involving pharmaceutical and life sciences companies with particular expertise in Hatch-Waxman litigation. Brown joined the firm’s New York office earlier this year.

Choy joins Latham & Watkins from Wilson Sonsini Goodrich & Rosati. He received his law degree from Boston University School of Law and a BA degree from the University of California, Los Angeles.

About Latham & Watkins
Latham & Watkins is a global law firm with approximately 2,000 attorneys in 31 offices, including Abu Dhabi, Barcelona, Beijing, Boston, Brussels, Chicago, Doha, Dubai, Frankfurt, Hamburg, Hong Kong, Houston, London, Los Angeles, Madrid, Milan, Moscow, Munich, New Jersey, New York, Orange County, Paris, Riyadh, Rome, San Diego, San Francisco, Shanghai, Silicon Valley, Singapore, Tokyo and Washington, D.C. For more information on Latham & Watkins, please visit the Web site at www.lw.com.
Notes to Editor
1 Latham & Watkins operates as a limited liability partnership worldwide with affiliated limited liability partnerships conducting the practice in the United Kingdom, France and Italy and affiliated partnerships conducting the practice in Hong Kong, Japan and Singapore. Latham & Watkins practices in Saudi Arabia in association with the Law Office of Mohammed Al-Sheikh.
Contacts

James E. Brandt, Office Managing Partner, New York, +1.212.906.1278

James C. Gorton, Global Co-Chair of the Corporate Department, +1.212.906.1804

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.